Fig. 7From: The clinicopathological significance of UBE2C in breast cancer: a study based on immunohistochemistry, microarray and RNA-sequencing dataUBE2C expression in ductal BRCA and other types of breast cancer from oncomine. UBE2C expression was remarkably higher in ductal BRCA than other types of breast cancer from oncomine (P = 8.64E−9, a; P = 5.44E−27, b; P = 7.12E−10, c; P = 0.008, d)Back to article page